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Pretreatment of tissues with potassium channel openers (KCO’s) has been observed to be cytopro-
tective in a broad variety of insults. This phenomenon has been proposed to be intimately linked
to activation of mitochondrial potassium channels which apparently modulate the mitochondrial
production of reactive oxygen species (ROS). This critical review summarizes literature ﬁndings
about the mitochondrial production of ROS, the action of KCO’s on mitochondrial ROS production
and the putative link to the cytoprotective action of these drugs.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction. Mitochondrial generation of reactive oxygen
species
Reactive oxygen species (ROS) are highly reactive molecules
originating from molecular oxygen which have been implicated
to be important for a broad variety of pathologies and ageing, as
well as for intracellular signaling [1]. The superoxide anion – the
product of one-electron reduction of oxygen – is the precursor of
most ROS. Its dismutation reaction produces hydrogen peroxide,
which in turn can be split by catalase to water and oxygen or with-
in the Fenton reaction partially reduced to the extremely reactive
hydroxyl radical. Well known cell speciﬁc enzymatic sources of
superoxide include NADPH oxidases, cytochrome P450-dependent
oxygenases and xanthine oxidase. In most tissues the primary
source of superoxide are certain redox centers of the mitochondrial
respiratory chain [2], which are able for single electron transfer at
the appropriate redox potential enabling reduction of molecular
oxygen, having a standard redox potential of 160 mV [3]. Several
sites within the mitochondrion have been implicated for donatingchemical Societies. Published by E
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.S. Kunz).these electrons, including FMNH2 of respiratory chain complex I
[4,5], and semiquinone at center ‘o’ of respiratory chain complex
III [6,7], which both are probably the most relevant sites for brain
and muscle tissue [8,9]. Moreover, several mitochondrial ﬂavopro-
teins, like the a-lipoamide dehydrogenase moiety of the a-ketoglu-
tarate dehydrogenase complex [10], the electron-transfer
ﬂavoprotein of the b-oxidation pathway [11] and a-glycerophos-
phate dehydrogenase [12] have been also suggested as possible
additional sites for mitochondrial ROS production.
As depicted in Scheme 1, the major sites at complex I and III re-
lease the membrane impermeable superoxide anion to different
compartments – the FMNH2 – site of complex I to the mitochon-
drial matrix space and the semiquinone center ‘o’ of complex III
to the intermembrane space [7,8,11]. While most experimental
data suggest that the complex I-produced superoxide anion re-
mains trapped in the matrix space [8,11], the complex III-produced
superoxide apparently can escape the intermembrane space
trough the voltage gated anion channel of the outer mitochondrial
membrane (VDAC; porin pore) [13]. On the other hand, the dismu-
tation product of superoxide – hydrogen peroxide – can cross the
mitochondrial inner membrane presumably by aquaporin 9 chan-
nels [14]. There have been also reports assuming matrix superox-
ide release via the mitochondrial chloride channel [15] but direct
experimental evidence for efﬁcient superoxide release by this
pathway is so far lacking.
Concerning the velocity of superoxide formation, it is important
to note, that this rate is controlled by two factors: (i) thelsevier B.V. All rights reserved.
Scheme 1. Localization of major mitochondrial superoxide producing sites at complexes I and III. SOD1, Cu,Zn superoxide dismutase; SOD2, Mn superoxide dismutase;
FMNH2, reduced ﬂavine adenine mononucleotide; SDH, succinate dehydrogenase; VDAC, voltage-dependent anion channel (porin pore); SQo, semiquinone anion at center ‘o’;
SQi, semiquinone anion at center ‘i’; Fe2S2, Rieske iron sulphur center; bH, ‘high potential’ cytochrome b562; bL, ‘low potential’ cytochrome b566; IMM, inner mitochondrial
membrane.
2044 D. Malinska et al. / FEBS Letters 584 (2010) 2043–2048concentration of the electron donors – FMNH2 or SQo – and (ii) the
concentration of oxygen [16]. As shown in Scheme 1, this implies
for the complex I site that processes which enhance the supply
of NADH or diminish its oxidation (inhibition of electron ﬂow
through respiratory chain) would increase the concentration of
FMNH2 thus increasing the rate of superoxide formation. In line
with this concept for complex I-dependent superoxide formation
the unique determinant appears to be the mitochondrial NAD-re-
dox state [9]. An important, pathology relevant process, proposed
to increase complex I-dependent ROS formation, is PTP opening,
leading to inhibition of NADH oxidation due to dissociation of
cytochrome c [17]. This mechanism is particularly important to ex-
plain increased ROS formation during reperfusion injury. Since the
redox state of the mitochondrial NAD system is controlled by sub-
strate supply (reducing equivalent inﬂux) and respiratory chain
activity (reducing equivalent efﬂux), it is clear that stimulation of
respiratory chain electron ﬂow by decrease of mitochondrial mem-
brane potential always would decrease the rate of complex I-
dependent superoxide formation. The respiratory activity is
strongly activated when uncouplers of the oxidative phosphoryla-
tion increase the proton permeability of mitochondrial membrane
and waste the redox energy by means of a futile proton cycle [18].
A physiological process which uses this principle is ‘mild mito-
chondrial uncoupling’, which has been proposed to ameliorate
the complex I-dependent ROS production by reducing reverse elec-
tron ﬂow [18,19]. These changes in mitochondrial energy metabo-
lism are promoted by uncoupling proteins [20] but the redox
energy can be also dissipated by rotenone-insensitive external
and internal NAD(P)H dehydrogenases or the alternative, cya-
nide-resistant, terminal oxidases (AOX) of plant, fungal and proto-
zoan mitochondria [21,22]. Both mechanisms decrease efﬁciency
of oxidative phosphorylation and increase electron transport,
resulting in a physiological control of complex I-dependent ROS
formation [23].On the other hand, the concentration of the semiquinone at cen-
ter ‘o’ of bc1 complex, which is the direct donor of electrons for
superoxide formation at complex III – SQo – is kinetically controlled
by the electron transfer reaction within the Q-cycle (Scheme 1).
Since the concentration of this relevant semiquinone species is
the highest at intermediate levels of CoQ reduction, this implies –
in contrast to complex I-dependent superoxide production – for
complex III a bell-shaped dependency of superoxide production
rate on the reduction state of the entire coenzyme Q pool [24]. That
explains experimental ﬁndings in presence of antimycin that at a
high initial state of CoQ reduction inhibitors of succinate oxidation,
like malonate or TTFA [24], but also protonophores and ionophores
enhanced superoxide formation rates from this particular site [25],
while on the other hand, complete inhibition of succinate dehydro-
genase inhibited ROS production [25]. This site is also due to the
limited activity of intermembrane space SOD1 [26] potentially able
to liberate superoxide to the cytosolic space (cf. Scheme 1). There-
fore, complex III-dependent ROS formation, which can potentially
be activated under conditions of a highly reduced coenzyme Q pool
by depolarization of mitochondrial inner membrane, but also by
inhibition of succinate dehydrogenase, could be important for the
activation of ROS-dependent signal transduction pathways. For this
reason it is plausible to suggest that this particular site might be in-
volved in the preconditioning effects observed upon application of
potassium channel openers (for details, see Section 3).2. Effects of potassium channel openers on mitochondrial ROS
production
After the functional identiﬁcation of potassium channels in the
inner mitochondrial membrane [27] and the demonstration, that
cytoprotective properties of certain potassium channel openers
(KCO’s) apparently result from stimulation of mitochondrial ROS
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relation between mitochondrial potassium ﬂuxes and ROS genera-
tion by the respiratory chain. The earliest and most intensively
studied mitochondrial potassium channel is the ATP regulated
channel (mitoKATP). Recently, also a mitochondrial large conduc-
tance calcium activated potassium channel (mitoBKCa) is gaining
increasing attention [29]. It is widely accepted that activation of
potassium channels in the inner mitochondrial membrane and, in
consequence, increasing potassium inﬂux into the matrix leads to
a decrease in mitochondrial membrane potential and consecutive
stimulation of respiration rate leading to matrix alkalinization
(Scheme 2, [30,31]). In contrary to mitochondrial calcium uptake,
where a decrease in membrane potential is a secondary effect
resulting from intracellular calcium buffering role played by mito-
chondria, potassium uptake by these organelles can be a conve-
nient mechanism for adjusting the mitochondrial metabolic state
to the needs of the cell. Yet, there is not much agreement on
how mitochondrial potassium ﬂuxes inﬂuence mitochondrial
superoxide generation. Studies on heart mitochondria provided
so far conﬂicting results: ROS production increased [32,33] or de-
creased [34,35] upon activation of potassium transport by applica-
tion of various potassium channel openers. Such inconsistency can
result from the complexity of responses of the different mitochon-Scheme 2. Potential effects of KCO’s on mitochondrial ROS production and there
putative link to cytoprotection. Thick red arrows indicate the expected effects of
KCO’s on the mitochondrial ROS producing sites at complexes I and III via mitoKATP
and mitoBKCa, dashed arrows indicate potential side effects. IMM – inner
mitochondrial membrane, OMM – outer mitochondrial membrane.
Table 1













Mild uncoupling [31] Inhibition Stimulation/no effecta
Matrix swelling [55] Inhibition Stimulation/no effecta
Inhibition of succinate
dehydrogenaseb [37]
Inhibition/no effect a Stimulation/no effecta
Inhibition of complex I of
respiratory chainb [38]
Stimulation Inhibitiona
a The effect depends on supply of reducing equivalents and applied mitochon-
drial substrates.
b Unspeciﬁc side effects of KCO’s not related to activation of mitochondrial
potassium channels.
c The relative amount of released superoxide depends on activity of SOD1 in the
mitochondrial intermembrane space (cf. [26]).drial superoxide-producing sites, described in the ﬁrst part of this
review. Additionally, the individual contributions of the different
superoxide-producing sites appear to be tissue dependent [2,8].
The predicted effects of increased potassium inﬂux into the matrix
on ROS production by complexes I and III are summarized in Ta-
ble 1. This possible site dependency of the observed effect on
superoxide generation has been also discussed by Heinen et al.
[35], who observed upon application of mitoBKCa opener NS
1619 a decrease of reverse electron ﬂow dependent ROS generation
(which is exclusively complex I-dependent), while forward elec-
tron ﬂow-dependent ROS generation (at least partially complex
III-dependent) was apparently stimulated by the same potassium
channel opener [33]. More recent observations made with isolated
brain mitochondria [36] indicated however a 20% decrease of
hydrogen peroxide production upon application of the mitoBKCa
openers CGS 7184 and NS 1619, irrespectively of the respiratory
substrates (succinate or glutamate + malate) applied. These effects
were observed to be strictly potassium selective. Moreover, the
speciﬁc inhibitors of the BKCa channel, charybdotoxin and iberio-
toxin, applied in nanomolar concentrations prevented the ob-
served inhibitory action of the potassium channel openers CGS
7184 and NS 1619 [36]. The differences in the effects observed
by Heinen et al. [33] and by Kulawiak et al. [36] might be related
to different contributions of the complex I- and complex III-depen-
dent superoxide generating sites in heart and brain mitochondria
[8]. Since in brain tissue the complex I-dependent superoxide gen-
eration has a higher contribution than the complex III-dependent
superoxide generation [8,9], the observed decrease in superoxide
production is in line with the already mentioned effects of opening
of potassium channels in inner mitochondrial membrane under
resting state conditions of highly reduced NAD-system and of high
resting state membrane potential. The net ﬂux of potassium ions
from the cytosol into the mitochondrial matrix space would lead
to a ‘mild uncoupling’, resulting in a lowered mitochondrial mem-
brane potential and lowered redox state of the NAD system leading
to a diminished concentration of FMNH2. This in turn would de-
crease the production of reactive oxygen species by respiratory
chain complex I (cf. Schemes 1 and 2).
It also needs to be mentioned that studying the mitochondrial
potassium channels is aggravated by the poor selectivity of avail-
able potassium channel openers. It appeared that the most widely
used opener of ATP-regulated potassium channel (KATP), diazox-
ide, apart from stimulating potassium inﬂux into the matrix can in-
hibit succinate dehydrogenase [37]. NS1619, the popular opener of
calcium-activated potassium channel (BKCa), was shown to inhibit
the activity of respiratory chain complex I [38]. Of course, such di-
rect modulation of the activity of respiratory complexes by KCO’s
strongly affects mitochondrial superoxide generation. In case of
the BKCa channel, the application of iberiotoxin and charybdotox-
in, highly selective peptide inhibitors with effective concentrations
in nanomolar range, allows quite reliable inhibitor-based controls.
About the most widely used inhibitor of the mitoKATP channel, 5-
hydroxydecanoic acid (5-HD) there is much more controversy. In
contrary to the BKCa inhibitors, where the interaction of the drug
with the channel is well described, the mechanism of the mito-
KATP inhibition by 5-HD is more elusive. Some observations sug-
gest even, that 5-HD can counteract the consequences of
channel-unrelated effects of diazoxide [37,39]. Thus, while investi-
gating the physiological role of mitochondrial potassium ﬂuxes
with the use of KCO’s a special attention should be paid to the
potassium- and inhibitor-sensitivity of the observed effects and
to the applied opener concentrations. Still, experiments with iso-
lated mitochondria showing that many of the KCO effects can be
reproduced with K+ ionophore valinomycin [32,33] favor the view
that the opener effects are indeed related to activation of mito-
chondrial potassium channels.
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ROS production on cellular survival
The cytoprotective effect obtained by pre-treatment of tissue
with certain potassium channel openers, like diazoxide, before an
insult is a well known phenomenon [40]. Application of KCO’s be-
fore exposing the tissue to ischemia and reperfusion strongly re-
duces the ischemic injury. A similar effect is obtained by
ischemic preconditioning (IPC), i.e., exposing the tissue to short
ischemic periods before the appearance of longer ischemia and
reperfusion. After the additional discovery, that IPC can be abol-
ished by potassium channel inhibitors, it was suggested that open-
ing of potassium channels is an event appearing in the
preconditioning phase and essential for the observed protective
effect.
The beneﬁcial action of KCO’s was mostly studied in cardiac tis-
sue exposed to ischemia and reperfusion. However, similar cyto-
protective effects were observed also in brain and kidney [41,42]
and under different insults, like exposure to hydrogen peroxide
or glutamate [43]. Since potassium channels are present both in
plasma membrane and in inner mitochondrial membrane both
sites can be the targets of KCO action. At present the prevailing
view is that the activation of channels located in mitochondria is
crucial for KCO-mediated cytoprotection [34,40]. Still, the link be-
tween modulation of mitochondrial function by KCO’s and cyto-
protection is not clear. Different hypotheses explain it as a
consequence of matrix volume modulation, of ‘mild uncoupling’
resulting in limited calcium uptake into the mitochondria and
diminished superoxide generation by the respiratory chain [34]
or, in contrary, of stimulation of mitochondrial ROS production,
which leads to the activation of pro-survival signaling pathways
[40]. The last assumption is supported by observations, that the
KCO-induced preconditioning is abolished by co-administration
of antioxidants and, in consequence, prevention of the opener-in-
duced stimulation of ROS generation [28,44,45]. The KCO-medi-
ated cytoprotection was often accompanied by stimulation of
redox sensitive kinases involved in pro-survival signaling path-
ways, like ERK [44,46] or PI3K [43]. In these studies the protective
effects of KCO’s were abolished by both kinase inhibitors and ROS
scavengers. Moreover, scavenging free radicals prevented ERK acti-
vation, showing that ROS generation is necessary for activation of
this kinase during preconditioning. The relation between decreas-
ing mitochondrial membrane potential, increased ROS generation
and preconditioning was demonstrated by Brennan et al. [47]. In
this study the preconditioning was achieved by application of
low doses of the uncoupler FCCP and the protective effect was
abolished by ROS scavengers.
As discussed in the previous part of this review, the Qo site of
complex III is the most probable superoxide-releasing site at which
superoxide production can be stimulated by increased potassium
inﬂux and subsequent decrease in membrane potential. The
assumption that ROS responsible for the preconditioning are orig-
inating from complex III is supported by observations, that the
cytoprotective effects are abolished by application of SOD mimet-
ics, which stimulate dismutation of superoxide to hydrogen perox-
ide [43,45]. Thus, the signaling molecule activating cytoprotective
pathways seems to be superoxide, which is released by complex III
to the cytosolic compartment (Schemes 1 and 2).
Preconditioning can be also achieved by exposing the tissue to
moderate doses of hydrogen peroxide before the ischemic insult
and interestingly, this H2O2 induced protection was sensitive to
the mitoKATP inhibitor 5-HD [48]. It seems then that in the pre-
conditioning cascade of events, increased ROS levels are not only
the consequence of activation of mitochondrial potassium chan-
nels but, in addition, can be responsible for the channel opening.This view is supported by demonstrations of redox sensitivity of
mitochondrial potassium ﬂuxes [49]. Other studies show the
dependence of mitoKATP activation on protein kinase Ce (PKCe).
Activation and translocation of this kinase to mitochondria is ob-
served during preconditioning [50] and PKCe is in turn known to
phosphorylate the ATP-regulated potassium channel, leading to in-
creased activation of the channel and further stimulation of potas-
sium inﬂux into the matrix [32].
During preconditioning a moderate increase in superoxide gen-
eration induced by KCO’s seems to be responsible for the beneﬁcial
effects of the openers. In contrary, the massive ROS production ob-
served during reperfusion and responsible for tissue damage ap-
peared to be limited by KCO pre-treatment [39,40]. Re-
introduction of oxygen after the hypoxic period, when respiratory
chain is highly reduced, results in strong stimulation of mitochon-
drial superoxide generation and this in turn leads to oxidative
damage of the cells. Antioxidant treatment can limit the reperfu-
sion-induced tissue damage, conﬁrming the crucial role of ROS in
this type of cell injury [51]. Thus, diminishing the reperfusion
ROS levels by KCO’s can be an important mechanism responsible
for their cytoprotective properties. In the KCO pre-treated tissue
not only the reperfusion ROS levels were lower, but also oxidative
damage of lipids and both nuclear and mitochondrial DNA were
limited [39,41]. The prevention of oxidative stress exerted by KCO’s
can therefore result from (i) activation of pro-survival signaling
pathways during the preconditioning phase (e.g., activation of
PKD leading to increased expression of SOD [52], as well as (ii)
from diminished complex I-dependent ROS generation due to de-
creased mitochondrial membrane potential (Scheme 2).
As discussed previously, ‘mild uncoupling’ as potential mecha-
nism to reduce ROS production has been proposed to explain tissue
protection against ROS toxicity [18,19]. Therefore, the data of Fac-
undo et al. [34], Heinen et al. [35] and Kulawiak et al. [36] report-
ing upon application of BK channel openers a decrease of
mitochondrial ROS production suggest that openers of BK channels
could in principle deploy their cytoprotective action by this partic-
ular mechanism.
The assumption that pharmacological preconditioning with
KCO’s is caused by opening of mitochondrial potassium channels
can be questioned due to doubtful speciﬁcity of the available
potassium channel modulators. Therefore, it has been suggested
that the diazoxide-mediated cardioprotection can be attributed
rather to inhibition of succinate dehydrogenase (SDH) [53] or the
protonophoric properties of the drug [54] than to activation of
potassium channels. Nevertheless, both mentioned side effects of
KCO’s would modulate mitochondrial ROS production in a similar
way (cf. Scheme 2, dashed arrows). They would lead to inhibition
of complex I-dependent ROS production – important for protection
against oxidative stress in the reperfusion phase – and at satura-
tion of substrate supply potentially to a stimulation of complex
III-dependent ROS production, which could be beneﬁcial for activa-
tion of pro-survival signaling pathways in the preconditioning
phase.
4. Concluding remarks
The cytoprotective actions of KCO’s are very likely related to
two different effects on mitochondrial ROS production: (i) Their
potential stimulation of complex III-dependent ROS production
which might be relevant for ROS triggered signal transduction to
the cytosol in the precondition phase and (ii) their established
inhibition of complex I-dependent ROS production in the matrix
compartment occurring in the reperfusion phase. Whether these
effects are directly caused by opening of mitochondrial potassium
channels, like mitoKATP or mitoBKCa, or are linked to possible side
D. Malinska et al. / FEBS Letters 584 (2010) 2043–2048 2047effects of the applied drugs remains to be elucidated yet. Addition-
ally, the potential impact of KCO-induced changes of ROS levels for
intracellular processes should be much better estimated applying
more precise quantitative measurements of the KCO-induced
changes of mitochondrial ROS release. Paradoxically, during ische-
mia and reperfusion ROS are responsible for both tissue injury and
preconditioning. Thus, it still remains an important goal to deter-
mine which types and which sources of ROS are involved in the
particular, beneﬁcial or deleterious effect. Since the efﬁcacy of gen-
eral antioxidant treatments, giving promising results in some
experimental systems of ischemia and reperfusion, was so far not
conﬁrmed in clinical practice, there is still a need for the develop-
ment of cytoprotective treatments targeted to the relevant sources
of ROS.
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